Hematological and Metabolical Changes Following Treatment with Radiolabeled anti-CD20 Antibody for Lymphoma

被引：0
|
作者：
Bural, G. G. [1 ]
Shrikanthan, S. [1 ]
Berkowitz, A. [1 ]
Schuster, S. [2 ]
Alavi, A. [1 ]
机构：
[1] Univ Penn, Nucl Med Hosp, Philadelphia, PA 19104 USA
[2] Ospital Univ Penn, Philadelphia, PA USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [1] Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma
    Dillman, RO
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3545 - 3557
  • [2] Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma
    Giovanni Antonini
    Maria Cristina Cox
    Enrico Montefusco
    Antonella Ferrari
    Esmeralda Conte
    Stefania Morino
    Pamela Latino
    Guido Trasimeni
    Bruno Monarca
    Journal of Neuro-Oncology, 2007, 81 : 197 - 199
  • [3] Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma
    Antonini, Giovanni
    Cox, Maria Cristina
    Montefusco, Enrico
    Ferrari, Antonella
    Conte, Esmeralda
    Morino, Stefania
    Latino, Pamela
    Trasimeni, Guido
    Monarca, Bruno
    JOURNAL OF NEURO-ONCOLOGY, 2007, 81 (02) : 197 - 199
  • [4] Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?
    Armitage, James O.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14): : 1389 - 1390
  • [5] Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab
    Woehrer, S
    Streubel, B
    Chott, A
    Hoffmann, M
    Raderer, M
    LEUKEMIA & LYMPHOMA, 2005, 46 (11) : 1645 - 1649
  • [6] Tetravalent anti-CD20/CD3 bispecific antibody for the treatment of B cell lymphoma
    Lu, Chia-Yen
    Chen, Gregory J.
    Tai, Pei-Han
    Yang, Yu-Chen
    Hsu, Yu-Shen
    Chang, Mingi
    Hsu, Chuan-Lung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 473 (04) : 808 - 813
  • [7] Ofatumumab - Human anti-CD20 monoclonal antibody treatment of lymphoma/leukemia treatment of rheumatoid arthritis
    Wang, Y.
    Mealy, N.
    Bays, M.
    DRUGS OF THE FUTURE, 2007, 32 (05) : 408 - 410
  • [8] Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab
    Schulz, H
    Pels, H
    Schmidt-Wolf, I
    Zeelen, U
    Germing, U
    Engert, A
    HAEMATOLOGICA, 2004, 89 (06) : 753 - 754
  • [9] Anti-CD20 monoclonal antibody as a new treatment modality for B-cell lymphoma
    Hotta, T
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2002, 35 (04) : 275 - 279
  • [10] Sars-CoV2 Antibody Responses in Patients with Hematological Malignancies Following Anti-CD20 Therapy
    Guerra, Veronica A.
    Ocampo, Marisol
    Cusnir, Mike
    BLOOD, 2021, 138
12345